Summary & Overview
HCPCS K1026: Mechanical Allergen Barrier/Inhalation Filter, Nasal Cream
HCPCS Level II code K1026 represents a topical nasal cream marketed as a mechanical allergen particle barrier or inhalation filter. The code covers a non-systemic, device-like topical formulation applied to the nasal mucosa to reduce exposure to airborne allergens. Nationally, such products matter because they offer an alternative or adjunct to pharmacologic therapies for allergic rhinitis and environmental allergen mitigation, which can affect clinical management pathways and durable medical supply considerations.
Key payers in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, typical sites of service (outpatient settings, physician offices, pharmacies, and home use), and the type of service billed under this descriptor. The publication summarizes payer coverage considerations where available, relevant billing modifiers and procedural context, and related coding touchpoints. It also highlights common operational questions payers and providers encounter when processing claims for device-like topical nasal products.
This national summary is intended to orient billing professionals, clinical coders, and policy analysts to the clinical purpose of K1026, the service environments in which it is used, and the areas where payers and clinicians typically seek clarity on coverage and coding treatment for non-systemic allergen barrier products.
Billing Code Overview
HCPCS Level II code K1026 describes a mechanical allergen particle barrier/inhalation filter, cream, nasal, topical. This product is a topical nasal cream intended to act as a physical barrier or filtration medium to reduce inhaled allergen exposure at the nasal mucosa.
Service type: Topical nasal barrier/inhalation filtration therapy
Typical site of service: Outpatient clinic, physician office, retail pharmacy, or home use
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric individual with seasonal allergic rhinitis or frequent airborne allergen exposure who seeks symptomatic relief and wants a nonpharmacologic option. The clinician (allergist, otolaryngologist, primary care physician, or pharmacist in jurisdictions where permitted) evaluates nasal symptoms, exposure history, and prior responses to intranasal medications. For patients who prefer barrier protection or who have contraindications to intranasal steroids/antihistamines, a topical mechanical allergen particle barrier such as K1026 (a cream nasal inhalation filter) may be applied in clinic or prescribed for home use.
Clinical workflow:
-
Patient presents with nasal congestion, sneezing, rhinorrhea, or itching associated with known allergen exposure.
-
History and focused nasal exam are performed; relevant ICD-10 diagnosis code(s) are selected and documented in the visit note.
-
The clinician discusses treatment options and documents informed consent for topical barrier use when applicable.
-
The device/cream
K1026is applied in-office by clinical staff or instructions are provided for patient self-application at home; education on frequency, precautions, and expected outcomes is documented. -
Follow-up plan is documented, including criteria for escalation to pharmacologic therapy or referral to allergy/immunology or otolaryngology if symptoms persist or worsen.